Compare Pfizer with Piramal Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs PIRAMAL ENTERPRISES - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER PIRAMAL ENTERPRISES PFIZER/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 33.4 18.4 181.3% View Chart
P/BV x 5.6 1.2 478.7% View Chart
Dividend Yield % 0.6 1.5 40.2%  

Financials

 PFIZER   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    PFIZER
Mar-18
PIRAMAL ENTERPRISES
Mar-19
PFIZER/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs2,3653,303 71.6%   
Low Rs1,6251,797 90.4%   
Sales per share (Unadj.) Rs430.3716.5 60.1%  
Earnings per share (Unadj.) Rs78.779.7 98.7%  
Cash flow per share (Unadj.) Rs93.2107.9 86.4%  
Dividends per share (Unadj.) Rs20.0028.00 71.4%  
Dividend yield (eoy) %1.01.1 91.3%  
Book value per share (Unadj.) Rs586.51,477.5 39.7%  
Shares outstanding (eoy) m45.75184.45 24.8%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x4.63.6 130.3%   
Avg P/E ratio x25.332.0 79.2%  
P/CF ratio (eoy) x21.423.6 90.6%  
Price / Book Value ratio x3.41.7 197.1%  
Dividend payout %25.435.1 72.3%   
Avg Mkt Cap Rs m91,271470,292 19.4%   
No. of employees `0002.67.8 33.6%   
Total wages/salary Rs m3,14322,504 14.0%   
Avg. sales/employee Rs Th7,484.816,899.4 44.3%   
Avg. wages/employee Rs Th1,195.02,877.7 41.5%   
Avg. net profit/employee Rs Th1,369.11,879.9 72.8%   
INCOME DATA
Net Sales Rs m19,685132,153 14.9%  
Other income Rs m1,1433,128 36.5%   
Total revenues Rs m20,828135,281 15.4%   
Gross profit Rs m5,00366,290 7.5%  
Depreciation Rs m6635,202 12.7%   
Interest Rs m444,097 0.0%   
Profit before tax Rs m5,47920,119 27.2%   
Minority Interest Rs m03,194 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,8788,611 21.8%   
Profit after tax Rs m3,60114,701 24.5%  
Gross profit margin %25.450.2 50.7%  
Effective tax rate %34.342.8 80.1%   
Net profit margin %18.311.1 164.4%  
BALANCE SHEET DATA
Current assets Rs m24,167122,742 19.7%   
Current liabilities Rs m9,544310,810 3.1%   
Net working cap to sales %74.3-142.3 -52.2%  
Current ratio x2.50.4 641.2%  
Inventory Days Days5523 238.8%  
Debtors Days Days2939 73.9%  
Net fixed assets Rs m9,514116,904 8.1%   
Share capital Rs m458369 124.0%   
"Free" reserves Rs m26,375272,161 9.7%   
Net worth Rs m26,832272,530 9.8%   
Long term debt Rs m25270,196 0.0%   
Total assets Rs m36,900856,261 4.3%  
Interest coverage x1,305.51.5 89,652.4%   
Debt to equity ratio x01.0 0.1%  
Sales to assets ratio x0.50.2 345.7%   
Return on assets %9.86.9 142.3%  
Return on equity %13.45.4 248.8%  
Return on capital %20.412.4 164.4%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m2215,200 0.1%   
Fx outflow Rs m1,4894,889 30.5%   
Net fx Rs m-1,46610,312 -14.2%   
CASH FLOW
From Operations Rs m3,318-115,975 -2.9%  
From Investments Rs m-2,383-8,265 28.8%  
From Financial Activity Rs m-1,104107,525 -1.0%  
Net Cashflow Rs m-169-16,650 1.0%  

Share Holding

Indian Promoters % 0.0 52.9 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 4.0 187.5%  
FIIs % 4.9 26.6 18.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 16.5 143.6%  
Shareholders   85,207 93,274 91.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   DIVIS LABORATORIES  WOCKHARDT  VENUS REMEDIES  FRESENIUS KABI ONCO.  GLENMARK PHARMA  

Compare PFIZER With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY20); Net Profit Up 390.0% (Quarterly Result Update)

Aug 1, 2019 | Updated on Aug 1, 2019

For the quarter ended June 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (up 390.0% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 9, 2019 | Updated on Jul 9, 2019

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

PFIZER Announces Quarterly Results (4QFY19); Net Profit Up 4.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, PFIZER has posted a net profit of Rs 1 bn (up 4.7% YoY). Sales on the other hand came in at Rs 5 bn (up 3.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (4QFY19); Net Profit Down 91.4% (Quarterly Result Update)

Apr 30, 2019 | Updated on Apr 30, 2019

For the quarter ended March 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 3 bn (down 91.4% YoY). Sales on the other hand came in at Rs 37 bn (up 23.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Sep 20, 2019 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS